Parkman Healthcare Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
283,166
+57,176
| +25% | +$6.14M | 3.5% | 3 |
|
|
2025
Q1 | $22.8M | Sell |
225,990
-111,364
| -33% | -$11.2M | 2.7% | 10 |
|
|
2024
Q4 | $30.1M | Sell |
337,354
-109,842
| -25% | -$9.81M | 4.01% | 4 |
|
|
2024
Q3 | $37.5M | Sell |
447,196
-104,396
| -19% | -$8.75M | 4.78% | 1 |
|
|
2024
Q2 | $42.5M | Buy |
551,592
+126,119
| +30% | +$9.71M | 5.69% | 1 |
|
|
2024
Q1 | $29.1M | Sell |
425,473
-227,330
| -35% | -$15.6M | 3.58% | 3 |
|
|
2023
Q4 | $37.7M | Buy |
652,803
+55,543
| +9% | +$3.21M | 5.32% | 1 |
|
|
2023
Q3 | $31.5M | Buy |
597,260
+124,155
| +26% | +$6.56M | 5.78% | 1 |
|
|
2023
Q2 | $25.6M | Buy |
473,105
+44,874
| +10% | +$2.43M | 4.44% | 2 |
|
|
2023
Q1 | $21.4M | Buy |
428,231
+60,298
| +16% | +$3.02M | 4.66% | 3 |
|
|
2022
Q4 | $17M | Buy |
367,933
+20,146
| +6% | +$932K | 4.53% | 2 |
|
|
2022
Q3 | $13.5M | Buy |
+347,787
| New | +$13.5M | 3.83% | 4 |
|
|
2020
Q1 | – | Sell |
-275,000
| Closed | -$12.4M | – | 69 |
|
|
2019
Q4 | $12.4M | Buy |
+275,000
| New | +$12.4M | 3.59% | 6 |
|